NCT04444869View on ClinicalTrials.gov

Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Cancer of the Head and NeckOropharynx CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaThroat Carcinoma
Interventions
DRUG

Cisplatin injection

Standard dose cisplatin given concurrently with radiation therapy

Trial Locations (1)

65203

RECRUITING

University of Missouri, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER